×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVAX – novavax, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/26
04:39 pm
nvax
Novavax to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Neutral
Report
Novavax to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/26
04:30 pm
nvax
Novavax to Participate in Upcoming Investor Conferences
Low
Report
Novavax to Participate in Upcoming Investor Conferences
2/26
04:01 pm
nvax
Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance]
Low
Report
Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance]
2/26
03:57 pm
nvax
Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance Canada]
Low
Report
Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance Canada]
2/26
03:11 pm
nvax
Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy [Seeking Alpha]
Low
Report
Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy [Seeking Alpha]
2/26
03:11 pm
nvax
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
01:13 pm
nvax
Why Is Novavax (NVAX) Stock Soaring Today [Yahoo! Finance]
Low
Report
Why Is Novavax (NVAX) Stock Soaring Today [Yahoo! Finance]
2/26
08:35 am
nvax
Earnings Snapshot: Novavax beats Q4 revenue estimates; introduces FY26 outlook [Seeking Alpha]
High
Report
Earnings Snapshot: Novavax beats Q4 revenue estimates; introduces FY26 outlook [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
2/26
08:02 am
nvax
Form 8-K NOVAVAX INC For: Feb 26
High
Report
Form 8-K NOVAVAX INC For: Feb 26
2/26
07:34 am
nvax
Form 10-K NOVAVAX INC For: Dec 31
High
Report
Form 10-K NOVAVAX INC For: Dec 31
2/11
02:12 pm
nvax
Form SCHEDULE 13G NOVAVAX INC Filed by: BANK OF AMERICA CORP /DE/
Low
Report
Form SCHEDULE 13G NOVAVAX INC Filed by: BANK OF AMERICA CORP /DE/
2/9
07:57 am
nvax
Form SCHEDULE 13G NOVAVAX INC Filed by: STATE STREET CORP
Medium
Report
Form SCHEDULE 13G NOVAVAX INC Filed by: STATE STREET CORP
1/26
07:58 pm
nvax
Form 4 NOVAVAX INC For: Jan 23 Filed by: Jacobs John C
Low
Report
Form 4 NOVAVAX INC For: Jan 23 Filed by: Jacobs John C
1/20
07:00 am
nvax
Form 8-K NOVAVAX INC For: Jan 15
Medium
Report
Form 8-K NOVAVAX INC For: Jan 15
1/12
08:01 am
nvax
Form 8-K NOVAVAX INC For: Jan 12
Medium
Report
Form 8-K NOVAVAX INC For: Jan 12
12/15
04:01 pm
nvax
Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
Low
Report
Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/14
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock.
40.5%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
TOP News Decliners
3/2
Form 8-K NOVAVAX INC For: Mar 02
-28.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: